Literature DB >> 24220207

PharmGKB summary: mycophenolic acid pathway.

Vishal Lamba1, Katrin Sangkuhl, Kinjal Sanghavi, Alyssa Fish, Russ B Altman, Teri E Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24220207      PMCID： PMC4091813          DOI： 10.1097/FPC.0000000000000010

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  63 in total

1.  IMPDH1 gene polymorphisms and association with acute rejection in renal transplant patients.

Authors:  J Wang; J W Yang; A Zeevi; S A Webber; D M Girnita; R Selby; J Fu; T Shah; V Pravica; I V Hutchinson; G J Burckart
Journal:  Clin Pharmacol Ther       Date:  2007-09-12       Impact factor: 6.875

2.  Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes.

Authors:  M Shipkova; C P Strassburg; F Braun; F Streit; H J Gröne; V W Armstrong; R H Tukey; M Oellerich; E Wieland
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

3.  Induction of cytokine release by the acyl glucuronide of mycophenolic acid: a link to side effects?

Authors:  E Wieland; M Shipkova; U Schellhaas; E Schütz; P D Niedmann; V W Armstrong; M Oellerich
Journal:  Clin Biochem       Date:  2000-03       Impact factor: 3.281

4.  Effect of mycophenolate acyl-glucuronide on human recombinant type 2 inosine monophosphate dehydrogenase.

Authors:  Olivier Gensburger; Nicolas Picard; Pierre Marquet
Journal:  Clin Chem       Date:  2009-03-19       Impact factor: 8.327

5.  UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients.

Authors:  R H N van Schaik; M van Agteren; J W de Fijter; A Hartmann; J Schmidt; K Budde; D Kuypers; Y Le Meur; M van der Werf; R Mamelok; T van Gelder
Journal:  Clin Pharmacol Ther       Date:  2009-06-03       Impact factor: 6.875

6.  The impact of P-glycoprotein and Mrp2 on mycophenolic acid levels in mice.

Authors:  Jian Wang; Michael Figurski; Leslie M Shaw; Gilbert J Burckart
Journal:  Transpl Immunol       Date:  2008-06-18       Impact factor: 1.708

7.  The prevalence of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T and its influence on mycophenolic acid pharmacokinetics in stable renal transplant patients.

Authors:  A I Sánchez-Fructuoso; M L Maestro; N Calvo; M Viudarreta; I Pérez-Flores; S Veganzone; V De la Orden; D Ortega; M Arroyo; A Barrientos
Journal:  Transplant Proc       Date:  2009 Jul-Aug       Impact factor: 1.066

8.  Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T > C polymorphism.

Authors:  Ferdi Sombogaard; Ron H N van Schaik; Ron A Mathot; Klemens Budde; Marloes van der Werf; Arnold G Vulto; Willem Weimar; Petra Glander; Laurent Essioux; Teun van Gelder
Journal:  Pharmacogenet Genomics       Date:  2009-08       Impact factor: 2.089

9.  Genetic polymorphisms of MRP2 and UGT2B7 and gastrointestinal symptoms in renal transplant recipients taking mycophenolic acid.

Authors:  Jae Wook Yang; Puay Hoon Lee; Ian V Hutchinson; Vera Pravica; Tariq Shah; David I Min
Journal:  Ther Drug Monit       Date:  2009-10       Impact factor: 3.681

10.  Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients.

Authors:  W-X Zhang; B Chen; Z Jin; Z Yu; X Wang; H Chen; A Mao; W Cai
Journal:  Xenobiotica       Date:  2008-11       Impact factor: 1.908
View more
  13 in total

Review 1.  Pharmacogenomics in dermatology: tools for understanding gene-drug associations.

Authors:  Roxana Daneshjou; Rachel Huddart; Teri E Klein; Russ B Altman
Journal:  Semin Cutan Med Surg       Date:  2019-03-01

Review 2.  Clinical Pharmacokinetics of Mycophenolic Acid in Hematopoietic Stem Cell Transplantation Recipients.

Authors:  Daping Zhang; Diana S-L Chow
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.441

3.  The correlation between the expression of genes involved in drug metabolism and the blood level of tacrolimus in liver transplant receipts.

Authors:  Jianhai Wang; Keqiu Li; Xiaoning Zhang; Dahong Teng; Mingyan Ju; Yaqing Jing; Yuxia Zhao; Guang Li
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

Review 4.  Economic Evaluation of Pharmacogenetic Tests in Patients Subjected to Renal Transplantation: A Review of Literature.

Authors:  Nemanja Rancic; Viktorija Dragojevic-Simic; Neven Vavic; Aleksandra Kovacevic; Zoran Segrt; Natasa Djordjevic
Journal:  Front Public Health       Date:  2016-08-31

5.  Vancomycin relieves mycophenolate mofetil-induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity.

Authors:  Michael R Taylor; Kyle L Flannigan; Hannah Rahim; Amina Mohamud; Ian A Lewis; Simon A Hirota; Steven C Greenway
Journal:  Sci Adv       Date:  2019-08-07       Impact factor: 14.136

6.  Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid.

Authors:  Laneshia K Tague; Derek E Byers; Ramsey Hachem; Daniel Kreisel; Alexander S Krupnick; Hrishikesh S Kulkarni; Catherine Chen; Howard J Huang; Andrew Gelman
Journal:  Pharmacogenomics J       Date:  2019-04-17       Impact factor: 3.550

7.  Mycophenolate suppresses inflammation by inhibiting prostaglandin synthases: a study of molecular and experimental drug repurposing.

Authors:  Fahad Al-Hizab; Mahmoud Kandeel
Journal:  PeerJ       Date:  2021-04-30       Impact factor: 2.984

8.  Association of ABCC2 Haplotypes to Mycophenolic Acid Pharmacokinetics in Stable Kidney Transplant Recipients.

Authors:  Daniel Brazeau; Calvin J Meaney; Joseph D Consiglio; Gregory E Wilding; Louise M Cooper; Rocco C Venuto; Kathleen M Tornatore
Journal:  J Clin Pharmacol       Date:  2021-07-20       Impact factor: 2.860

Review 9.  Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.

Authors:  Miriam G Mooij; Anne T Nies; Catherijne A J Knibbe; Elke Schaeffeler; Dick Tibboel; Matthias Schwab; Saskia N de Wildt
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447

10.  Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers.

Authors:  Jae Hyun Kim; Nayoung Han; Myeong Gyu Kim; Hwi-Yeol Yun; Sunhwa Lee; Eunjin Bae; Yon Su Kim; In-Wha Kim; Jung Mi Oh
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.